QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Secures USPTO Notice of Allowance for 3D-Beam Modulation Filter Patent
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, today announced its receipt of a Notice of Allowance in response to a patent application from the United States Patent and Trademark Office (“USPTO”). According to the update, the patent pertains to a specialized 3D x-ray filter, known as a 3D-Beam Modulation Filter, designed to tailor the shape of the IzoView x-ray beam to match the shape of the patient's breast being scanned. The filter provides patient and output benefits by…